ClinicalTrials.gov
ClinicalTrials.gov Menu

Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00318604
Recruitment Status : Unknown
Verified April 2006 by Far Eastern Memorial Hospital.
Recruitment status was:  Not yet recruiting
First Posted : April 27, 2006
Last Update Posted : May 12, 2006
Sponsor:
Information provided by:
Far Eastern Memorial Hospital

Brief Summary:
This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.

Condition or disease
Head and Neck Cancer Esophageal Cancer

Study Type : Observational
Time Perspective: Longitudinal
Time Perspective: Prospective

Resource links provided by the National Library of Medicine

U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Head and neck cancers
  • Esophageal cancer
  • Undergoing anti-cancer treatments

Exclusion Criteria:

  • No distant metastasis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00318604


Sponsors and Collaborators
Far Eastern Memorial Hospital
Investigators
Principal Investigator: LeJung Wu, MD, DPhil Far Eastern Memorial Hospital

ClinicalTrials.gov Identifier: NCT00318604     History of Changes
Other Study ID Numbers: 94042
First Posted: April 27, 2006    Key Record Dates
Last Update Posted: May 12, 2006
Last Verified: April 2006

Keywords provided by Far Eastern Memorial Hospital:
plasma circulating DNA
hean and neck cancers
esophageal cancer
localized head and neck cancers
localized esophageal cancer

Additional relevant MeSH terms:
Head and Neck Neoplasms
Esophageal Neoplasms
Neoplasms by Site
Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Digestive System Diseases
Esophageal Diseases
Gastrointestinal Diseases